Is FDA-Cleared Sonopet 3 Transforming the Investment Case for Stryker’s Surgical Platform Strategy (SYK)?

Earlier this month, Stryker received FDA 510(k) clearance for Sonopet 3, its new ultrasonic bone and soft tissue removal platform, incorporating surgeon-driven enhancements in power, precision, workflow integration and connectivity ahead of a planned full commercial launch later this fall. The clearance underscores Stryker’s push to pair advanced surgical hardware with digital tools such as its RISE connected workflow and Pulse Control technology, potentially deepening its presence in...